Genovis

• The Balance Sheet and Income Statement as well as the Consolidated Income Statement and the Consolidated Balance Sheet were adopted.
• The Board and the Chief Executive Officer were discharged from liability.
• The Board shall consist until the next AGM of five ordinary members without deputies.
• Re-election of Board members Torben Jørgensen, Mikael Lönn, Lotta Ljungqvist, Steve Jordan and Magnus Gustafsson. Torben Jørgensen was elected Chairperson of the Board
• Remuneration will be paid to the Board of Directors in the amount of SEK 230,000 to Board members and SEK 575,000 to the Chairperson of the Board.
• Remuneration to the auditors will be paid on approved account.
• In accordance with the Nomination Committee’s proposal, the Meeting re-elected the accounting firm Öhrlings PricewaterhouseCoopers AB as auditor for the period until the close of the Annual General Meeting 2026.
• A Nomination Committee will be formed with representatives of the four largest shareholders on September 30, 2025.
• The AGM resolved on the authorization to issue shares with or without preferential rights for existing shareholders. As a result of this resolution, share capital could increase by a maximum of SEK 1,625,000 through the issuance of a maximum of 6,500,000 shares.

Minutes with all resolutions from the meeting will be made available on the company's website: https://investor.genovis.com/en/corporate-governance/general-meeting/